Zoryve (roflumilast cream) is a new addition to the arsenal of non-steroidal topical therapies for mild to moderate plaque psoriasis. Mechanism of Action: Unlike traditional corticosteroids, Zoryve employs a unique mechanism of action by inhibiting phosphodiesterase type 4 (PDE4). This is the same target as the oral medication Otezla and the topical eczema medication Eucrisa.… Read More
